Here are the 424B prospectus supplements from MetLife, Inc. (MET) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow MET and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MET filings page.
MetLife, Inc. is offering $1,000,000,000 of 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due March 15, 2056. The Debentures pay 5.850% through the Initial Interest Reset Date of March 15, 2036, then reset every five years to the Five-Year Treasury Rate plus 1.817%. Interest is payable semi-annually on March 15 and September 15, beginning September 15, 2026. MetLife may defer interest for Optional Deferral Periods up to five years, and the Debentures are unsecured and subordinated to MetLife’s senior indebtedness and structurally subordinated to subsidiary liabilities. Net proceeds are expected to be approximately $987.8 million for general corporate purposes, with settlement expected on or about February 26, 2026.
MetLife, Inc. is offering fixed-to-fixed reset rate subordinated debentures due 2056 via a preliminary prospectus supplement dated February 24, 2026, supplementing the May 16, 2025 prospectus. The securities are unsecured, subordinated obligations that rank pari passu with the 2055 SDs and junior to MetLife’s senior indebtedness and subsidiary liabilities. Interest is payable semi-annually and initially fixed through the Initial Interest Reset Date, thereafter resetting each five years to the Five-Year Treasury Rate plus a spread. MetLife may defer interest for up to five consecutive years per Optional Deferral and may redeem the Debentures under specified conditions, including Tax, Rating Agency or Regulatory Capital Events. The Debentures will be issued in book-entry form and are not listed on any exchange.